Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive153AccountSocial
MARKETSINVESTLIVE153
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
  1. Medicine

Will the FDA approve retatrutide?



AI Digest · Eli Lilly's retatrutide approval before 2028 gains ground as FDA tightens GLP-1 eye warnings

1d ago

Kalshi traders favor the FDA approving drugmaker Eli Lilly's retatrutide before Jan 1, 2028, and that view gained ground this week. The FDA is making makers of GLP-1 drugs like Ozempic and Zepbound add warnings about a rare blinding eye condition, The Hill reports. The warning covers drugs already on the market, and the notice does not name retatrutide. Retatrutide is Lilly's experimental weight-loss drug, and the FDA has not yet approved it.

  • The Hill

    The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters

Chance

72%

72%

91%

91%

89%

89%

2 more

Before Jul 1, 2028
91%
Before Jan 1, 2029
89%
Before Jan 1, 2028
72%
50%62.5%75%87.5%100%MayJulAugOctNov
$121,204 vol
More Science and Technology Markets

Trending Science and Technology markets

Will the U.S. confirm that aliens exist?Best AI at the end of 2026?OpenRouter token usage in Nov 16–22, 2026When will the Riemann Hypothesis be resolved?When will P vs NP be resolved?Anthropic market share this weekWhere will Waymo operate this year?Google share of spend today (Vercel)

Science and Technology hub

All Science and Technology markets
Will the FDA approve retatrutide?

Before Jan 1, 2027

Odds
2% chance
Max payout
Dec 31, 2026
$0